Radek Pádr
Charles University in Prague
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Radek Pádr.
World Journal of Surgical Oncology | 2009
Robert C.G. Martin; Ken Robbins; Dana Tomalty; Ryan O'Hara; Petar Bosnjakovic; Radek Pádr; Miloslav Rocek; Frantisek Slauf; Cliff Tatum
BackgroundFollowing failure of standard systemic chemotherapy, the role of hepatic transarterial therapy for colorectal hepatic metastasis continues to evolve as the experience with this technique matures. The aim of this study to gain a better understanding of the value of drug eluting bead therapy when administered to patients with unresectable colorectal hepatic metastasis.MethodsThis was an open-label, multi-center, single arm study, of unresectable colorectal hepatic metastasis patients who had failed standard therapy from 10/2006-10/2008. Patients received repeat embolizations with Irinotecan loaded beads(max 100 mg per embolization) per treating physicians discretion.ResultsFifty-five patients underwent 99 treatments using Irinotecan drug eluting beads. The median number of total treatments per patient was 2(range of 1-5). Median length of hospital stay was 23 hours(range 23 hours - 10 days). There were 30(30%) sessions associated with adverse reactions during or after the treatment. The median disease free and overall survival from the time of first treatment was 247 days and 343 days. Six patients(10%) were downstaged from their original disease status. Of these, four were treated with surgery and two with RFA.Neither number of liver lesions, size of liver lesions or extent of liver replacement(<= 25% vs >25%) were predictors of overall survival. Only the presence of extrahepatic disease(p = 0,001), extent of prior chemotherapy (failed 1st and 2nd line vs > 2 line failure)(p = 0,007) were predictors of overall survival in multivariate analysis.ConclusionChemoembolization using Irinotecan loaded beads was safe and effective in the treatment of patients as demonstrated by a minimal complication rate and acceptable tumor response.
Journal of NeuroInterventional Surgery | 2018
Ondrej Volny; Antonín Krajina; Silvie Belaskova; Michal Bar; Petra Cimflová; Roman Herzig; Daniel Sanak; Ales Tomek; Martin Köcher; Miloslav Rocek; Radek Pádr; Filip Cihlar; Miroslava Nevsimalova; Lubomir Jurak; Roman Havlicek; Martin Kovar; Petr Sevcik; Vladimir Rohan; Jan Fiksa; Bijoy K. Menon; Robert Mikulik
Background Randomized clinical trials have proven mechanical thrombectomy (MT) to be a highly effective and safe treatment in acute stroke. The purpose of this study was to compare neurothrombectomy data from the Czech Republic (CR) with data from the HERMES meta-analysis. Methods Available nationwide data for the CR from 2016 from the Safe Implementation of Treatments in Stroke–Thrombectomy (SITS-TBY) registry for patients with terminal internal carotid artery (ICA) and/or middle cerebral artery (MCA) occlusions were compared with data from HERMES. CR and HERMES patients were comparable in age, sex, and baseline National Institutes of Health Stroke Scale scores. Results From a total of 1053 MTs performed in the CR, 845 (80%) were reported in the SITS-TBY. From these, 604 (72%) were included in this study. Occlusion locations were as follows (CR vs HERMES): ICA 22% versus 21% (P=0.16), M1 MCA 62% versus 69% (P=0.004), and M2 MCA 16% versus 8% (P<0.0001). Intravenous thrombolysis was given to 76% versus 83% of patients, respectively (P=0.003). Median onset to reperfusion times were comparable: 232 versus 285 min, respectively (P=0.66). A modified Thrombolysis in Cerebral Infarction score of 2b/3 was achieved in 74% (433/584) versus 71% (390/549) of patients, respectively (OR 1.17, 95% CI 0.90–1.5, P=0.24). There was no statistically significant difference in the percentage of parenchymalhematoma type 2 (OR 1.12, 95% CI 0.66–1.90, P=0.68). A modified Rankin Scale score of 0–2 at 3 months was achieved in 48% (184/268) versus 46% (291/633) of patients, respectively (OR 0.92, 95% CI 0.71–1.18, P=0.48). Conclusions Data on efficacy, safety, and logistics of MT from the CR were similar to data from the HERMES collaboration.
BMC Musculoskeletal Disorders | 2017
Fulín P; Martin Kysilko; David Pokorny; Radek Pádr; Nikola Kasprikova; Landor I; Antonin Sosna
BackgroundPreoperative planning with the aid of imaging methods is a principal factor in successful surgery on the shoulder. This work aims to evaluate the variability of glenoid version, spiralling twist and scapular inclination in relation to the frontal axis. Studies focusing on measuring the variability of scapular inclination in the standardised rest position are lacking in the literature.MethodsWe evaluated 104 CT scans of the shoulder. We measured the glenoid version with respect to the scapular axis at three levels. We measured the scapular inclination angle in relation to the sagittal plane and we determined scapular inclination in relation to the frontal axis. Statistical evaluation was performed using the marginal linear model and parameters were estimated using the generalised least squares method, which enables the dependency of measurements performed on the same subject to be taken into consideration.ResultsThe highest values of retroversion are attained by the glenoid in the cranial section (average -9.96°, range -29.7 to +13.2°). Proof of the spiralling twist is the decline in retroversion at the centre of the glenoid (average -2.09°, range -16.7 to +11.6°).Retroversion decreases further in the inferior direction (average -0.5°, range -20.9 to +17.5°). The average thoracoscapular angle is 45.46°, ranging from 13.1 to 69.0°. The average scapular inclination in relation to the frontal plane is 44.54°, ranging from 21.0 to76.9°.ConclusionsDuring preoperative planning, the surgeon should take into consideration not only the glenoid version in relation to the scapular axis, but also the value of the scapular inclination so as to eliminate possible surgical errors, optimise prosthesis implantation and thus decrease the risk of functional restrictions of the joint.Clinical trial registrationEthics Committee for Multi-Centric Clinical Trials (EK-554/14,29thApril 2014).
Vasa-european Journal of Vascular Medicine | 2018
Karel Novotný; Míla Roček; Radek Pádr; Radim Pavlík; Michal Polovinčák; Theodor Adla; Petra Zimolová; Jana Choi-Širůčková; Martin Weis; Simon Jirát; Vilém Rohn
BACKGROUND Treating great and small saphenous vein trunk insufficiency with cyanoacrylate glue is the least taxing treatment method of all available techniques. Due to long-term unavailability of commercial kits with n-butyl-2-cyanoacrylate (histoacryl) in the Czech Republic, we used a modified technique. PATIENTS AND METHODS Fifty-six limbs in 49 patients suffering from great saphenous vein or small saphenous vein insufficiency in combination with symptomatic chronic venous insufficiency and complicating comorbidities were treated with a modified endovascular cyanoacrylate glue application technique. RESULTS The immediate success rate of the treatment was 98 %. In follow-up intervals of six weeks, six months, one year, and two years, the anatomical success rates of embolization (recanalization of no more than 5 cm of the junction) were 98, 96, 94, and 94 %, respectively. At identical intervals the venous insufficiency was scored according to the Aberdeen Varicose Vein Questionnaire and the American Venous Clinical Severity Score. In both cases, improvement was demonstrated over the two-year follow-up, with a 0.5 % significance level. Specific clinical signs of venous insufficiency were also evaluated, such as pain, oedema, clearance of varicose veins, and healing of venous ulceration. One severe complication - a pulmonary embolism - was reported, without consequences. CONCLUSIONS We demonstrated that treating insufficient saphenous veins with modified histoacryl application brought a relief from symptoms of venous insufficiency and that the efficiency of this technique is comparable to commonly used methods.
Annals of Surgical Oncology | 2011
Robert C.G. Martin; Jonathan Joshi; Ken Robbins; Dana Tomalty; Petar Bosnjakovik; Milous Derner; Radek Pádr; Miloslav Rocek; Cliff Tatum
CardioVascular and Interventional Radiology | 2010
Robert C.G. Martin; J. Howard; Dana Tomalty; Ken Robbins; Radek Pádr; Petar Bosnjakovic; Cliff Tatum
Ceska A Slovenska Neurologie A Neurochirurgie | 2017
Ondřej Volný; Michal Bar; Antonín Krajina; Petra Cimflová; Linda Kašičková; Roman Herzig; Daniel Šaňák; Ondřej Škoda; Ales Tomek; David Školoudík; Daniel Václavík; Jiří Neumann; Martin Köcher; Miloslav Rocek; Radek Pádr; Filip Cihlář; Robert Mikulik
Ceska A Slovenska Neurologie A Neurochirurgie | 2016
Daniel Šaňák; Jiří Neumann; Ales Tomek; David Školoudík; Ondřej Škoda; Robert Mikulik; Daniel Václavík; Michal Bar; Miloslav Rocek; Antonín Krajina; Martin Köchler; František Charvát; Radek Pádr; Filip Cihlář
Stroke | 2018
Ondrej Volny; Silvie Belaskova; Antonín Krajina; Michal Bar; Petra Cimflová; Roman Herzig; Daniel Sanak; Ales Tomek; Martin Köcher; Miloslav Rocek; Radek Pádr; Filip Cihlar; Miroslava Nevsimalova; Lubomir Jurak; Roman Havlicek; Martin Kovar; Vladimir Rohan; Jan Fiksa; Robert Mikulik
CardioVascular and Interventional Radiology | 2018
Martin Köcher; Daniel Šaňák; Jana Zapletalova; Filip Cihlář; Daniel Czerný; David Černík; Petr Duras; Ladislav Endrych; Roman Herzig; Jiří Lacman; Miroslav Lojík; Svatopluk Ostrý; Radek Pádr; Vladimir Rohan; Miroslav Škorňa; Martin Šrámek; Luděk Štěrba; Daniel Václavík; Jiří Vaníček; Ondřej Volný; Ales Tomek